Dr. Scott Lipkin on Diversity in Clinical Trials at Miami Cancer Institute

The Miami Cancer Institute is one of the leading organizations in diversity amongst its clinical trials, and chief research officer Scott Lipkin, DPM, CIP, spoke on the present and future of diversity within the organization.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news